The prevailing assumption in endurance fitness is that cardiovascular training volume and longevity track together in a straight line. More kilometres logged, more hours at elevated heart rate, better long-term outcomes. It is an intuitive position, and it holds up at moderate doses. Where it breaks down is at the high end of the volume range — the range that ambitious, health-motivated exercisers are most likely to occupy.
In Singapore, where ActiveSG parks fill before sunrise and the culture around cardiovascular fitness defaults to more rather than less, this nuance rarely enters the conversation. The assumption that hard training equals better outcomes is embedded in how fitness culture frames commitment. The research tells a more specific story.
The Belief
High cardiovascular training volume is linearly protective: every additional hour at elevated heart rate extends the longevity benefit proportionally. This assumption underpins training cultures that prize weekly mileage totals as markers of health commitment, treat rest days with suspicion, and frame the default response to a health concern as adding more cardiovascular work. High-intensity formats such as HIIT and marathon training add intensity as a second virtue layered on top of volume, reinforcing the premise that physiological effort and longevity benefit scale together without limit.
What the Research Shows
The Copenhagen City Heart Study, a prospective cohort of 5,048 adults tracked across more than two decades, provides the most cited population-level data on exercise dose and all-cause mortality. The research suggests that light and moderate joggers — those running two to three sessions per week at a slow or moderate pace — showed significantly lower all-cause mortality than sedentary participants. Strenuous joggers, defined in the study as those running more than four times per week at fast paces for high total weekly distances, showed mortality rates comparable to sedentary individuals rather than to their moderate-jogging counterparts. (Schnohr et al., Journal of the American College of Cardiology, 2015.)
This U-shaped relationship — where cardiovascular mortality benefit rises with exercise dose up to a threshold, then plateaus and may reverse slightly at extremes — is referred to in the exercise science literature as the J-curve, named for the shape of the mortality curve when plotted against cumulative exercise volume.
The J-curve does not imply that high-volume training is acutely harmful in the way that smoking or metabolic dysfunction is harmful. What the data shows is that the longevity benefit of cardiovascular exercise is not proportional across the full dose range, and that at high volumes the additional return diminishes substantially and may reverse for some individuals.
The mechanistic basis for this sits at the intersection of cardiac physiology and cumulative physiological stress. Preliminary research indicates that prolonged high-intensity endurance exposure — specifically, multi-year high-volume training — is associated with structural cardiac changes including right ventricular remodelling and fibrosis markers measurable on cardiac MRI, patterns that do not appear in moderate-exercise populations. O'Keefe and colleagues, writing in Heart (2012), proposed that chronic excessive endurance exercise may attenuate longevity benefit by inducing pathological cardiac adaptations. The research establishing whether these structural signals translate to adverse clinical outcomes at population scale is ongoing and not yet settled.
What is more firmly established is the dose at which the longevity benefit concentrates. The research confirms that 150 to 300 minutes per week of moderate-intensity aerobic activity — or 75 to 150 minutes per week of vigorous-intensity activity — captures the substantial majority of the cardiovascular mortality benefit available from exercise. (Physical Activity Guidelines Advisory Committee, US Department of Health and Human Services, 2018; consistent with the AHA position statement, Circulation, 2019.) Additional volume beyond that threshold does not proportionally extend the longevity benefit, and the Copenhagen data suggests it may modestly reverse it in some individuals.
The implication is specific: the question is not whether to exercise. It is whether the volume and intensity structure you are currently running is actually optimised for longevity, or optimised for the feeling of effort.
What to Do Instead
The evidence does not support reducing cardiovascular training. It supports restructuring it around two principles: appropriate dose and compositional balance.
Anchor on Zone 2 aerobic work. Zone 2 training (approximately 60–70% of maximum heart rate, at an intensity where continuous conversation remains comfortable) builds mitochondrial density in slow-twitch muscle fibre without generating the cumulative physiological stress associated with high-volume high-intensity training. The research confirms that sustained Zone 2 work over twelve or more weeks produces measurable improvements in mitochondrial function, fat oxidation at submaximal intensities, and cardiovascular efficiency. (Hood et al., Cell Metabolism, 2019.) Two to three Zone 2 sessions per week at 45–60 minutes each delivers the aerobic base-building stimulus the evidence supports, without approaching the dose range where returns diminish.
Add resistance training. The research confirms that combined aerobic and resistance training produces superior all-cause mortality benefit compared with either modality in isolation. A large prospective analysis published in the British Journal of Sports Medicine (Kamada et al., 2017) found that the combination of aerobic work and muscle-strengthening activity was associated with the lowest risk across cardiovascular and cancer mortality categories. Two compound resistance sessions per week is the minimum effective dose for longevity-relevant adaptation.
Treat high-intensity cardio as an occasional input, not a weekly default. If training objectives require higher-intensity work, one structured interval session per week is consistent with preserving the longevity benefit without accumulating the volume that erodes it. Intensity is not the variable to eliminate — it is the variable to modulate.
Use HRV as a recovery throttle. Heart rate variability (HRV) — the beat-to-beat variation in cardiac interval reflecting autonomic nervous system recovery state — declines predictably when training load outpaces recovery capacity. A downward HRV trend sustained across five or more consecutive days is a reliable signal that volume should reduce rather than hold or increase. The longevity-optimised protocol uses HRV as a throttle: when recovery is incomplete, the protocol pulls back.
The Copenhagen study's strenuous joggers were not sedentary people who gave up. They were committed, high-volume exercisers. What separated their mortality profile from moderate joggers was not motivation or fitness — it was dose. The variable that determined outcomes was structure, not effort.
Now you know what the standard approach misses. The guide shows you what to do instead, starting tomorrow. Download the 30-Day Biohacking Starter Guide
